tirzepatide and naion GLP-1 RAs and NAION: What Clinicians Should Know Zepbound and NAION: 1 Permanently

Novo Nordisk faces a challenge turning around the fortunes of residents in a major Danish manufacturing hub.

Clinical data reveals Retatrutide dropped A1C from 8.1% to 6.08% in diabetic participants

We explore the concept and examine whether theres any truth behind the myth of a 5th semaglutide dose

Conclusion Adults with T2D initiating semaglutide OW in the real-world had significant decreases in weight, BMI, and HbA1c after 1 year, with greater improvements versus SGLT2i, and similar HCRU.

Learn why GLP-1 slows gastric emptying, how GERD develops, and 8 strategies that bring real relief fast.

Issue 42 of The Altascientist explores GLP-1 receptor agonist drug development, covering preclinical models, bioanalytical assays, clinical study design, and manufacturing